Antineoplastic effects of selective CDK9 inhibition with atuveciclib on cancer stem-like cells in triple-negative breast cancer

Treatment options for triple-negative breast cancer (TNBC) are limited due to the lack of efficient targeted therapies, frequently resulting in recurrence and metastatic disease. Accumulating evidence suggests that a small population of cancer stem-like cells (CSLCs) is responsible for tumor recurre...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Brisard, Daphne, Eckerdt, Frank, Marsh, Lindsey A., Blyth, Gavin T., Jain, Sarika, Cristofanilli, Massimo, Horiuchi, Dai, Platanias, Leonidas C.
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2018
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6324664/
https://ncbi.nlm.nih.gov/pubmed/30647871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26468
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires